Global market size
Last updated
Last updated
Increasing technological advancements related to digital genomes, adopting personalized medical services, evolving disease patterns, and increasing research and development on digital genomes support market growth.
The growth of the bioDID market is the result of a combination of advances in the precise analysis and secure management of genetic information, the growing demand for personalized health solutions, and the ongoing concern for privacy and data security. The bioDID market recognizes the importance of genetic information as a key factor in the development of solutions to optimize an individual's health, prevent disease, and treat it.
The global biomarker market size was approximately $59.1 billion in 2023 and is expected to reach approximately $104 billion by 2028.
This growth represents a compound annual growth rate (CAGR) of approximately 12.0% over the forecast period. The market is showing promising growth prospects due to biomarkers’ important role in diagnostics, drug discovery, and development of personalized medicine strategies.
